Efficacy and Safety of Remimazolam Besylate versus Dexmedetomidine for Sedation in Non-Intubated Older Patients with Agitated Delirium After Orthopedic Surgery: A Randomized Controlled Trial [Corrigendum]
Deng Y, Qin Z, Wu Q, et al. Drug Des Devel Ther. 2022;16:2439‒2451. The authors have informed the journal that Remimazolam Tosilate was used in this study, not Remimazolam Besylate as indicated throughout the paper. The authors apologize for any confusion this may have caused.
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2022-08-01
|
| Series: | Drug Design, Development and Therapy |
| Online Access: | https://www.dovepress.com/corrigendum-efficacy-and-safety-of-remimazolam-besylate-versus-dexmede-peer-reviewed-fulltext-article-DDDT |